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doi:10.1016/j.ejvsextra.2010.05.004Abstract Introduction: Rare case of a 39-year-old presenting with the triad of aortic dissec-
tion, hypertension and aldosterone-secreting adrenal tumour.
Report: We discuss his management, in the acute setting and long term.
Discussion: Hyperaldosteronism is increasingly recognised as a secondary cause of hyperten-
sion and is associated with higher cardiovascular complication rates than would be expected
due to hypertension alone. We discuss management of a young hypertensive patient presenting
with acute aortic dissection as implemented at a tertiary referral centre for Vascular Surgery.
We consider the possibility that hyperaldosteronism may represent a risk factor for aortic
dissection independent of elevated blood pressure.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license .Introduction
Type-B aortic dissection can be fatal and cause significant
morbidity amongst survivors.1 It is most commonly seen in
hypertensive patients. Hyperaldosteronism is a recognized
cause of non-essential hypertension and is associated withjvs.2010.05.023.
y’s Regional Vascular Unit,
Imperial College Healthcare
Street, London W2 1NY, UK.
perial.ac.uk (K.L. Harvey).
or Vascular Surgery. Published byhigher cardiovascular complication rates than would be
expected with hypertension alone.2 We report a rare triad
of aortic dissection, hypertension and an aldosterone-
secreting adrenal tumour. To our knowledge, there are
seven other reported cases of aortic dissection in patients
with primary hyperaldosteronism.3
Case Report
A 39-year-old Romanian man presented with left-sided renal
angle pain. He was a smoker and had been diagnosed with
hypertension 10 years previously. He took no anti-hyperten-
sive or other medications. His blood pressure (BP) on presen-
tation was 180/110 mmHg. Clinical examination wasElsevier Ltd.Open access under CC BY-NC-ND license .
Figure 2 A 3-Dimensional reconstruction of computed
topography images; showing Stanford type-B or DeBakey type-3
aortic dissection with entry point. A mass is visible in the upper
pole of the left adrenal gland.
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strated hypokalaemia (serumpotassium: 2.5 mmol/l), normal
random serum cortisol (126 nmol/l), elevated plasma aldo-
sterone (680 pmol/L), suppressed plasma renin activity
(0.2 pmol/mL/hour) and elevated aldosterone:renin ratio
(3400). A diagnosis of primary hyperaldosteronism was made.
A computed tomography (CT) scan demonstrated a left-sided
adrenal mass consistent with adrenal adenoma. He was
commenced on an aldosterone-antagonist and discharged.
The patient’s General Practitioner continued to be respon-
sible for BP modification.
Six months later he re-presented with low back pain,
hypertension (240/100 mmHg) and pyrexia. CT angiography
demonstrated an acute aortic dissection distal to the origin
of the left subclavian artery and extending to the left
common iliac and right external iliac arteries respectively
(i.e. Stanford type-B or DeBakey type-3;(Fig. 1) Trans-
oesophageal echocardiogram confirmed the absence of
a Stanford type-A proximal extension, despite retrograde
intramural haematoma. In the absence of organ malperfu-
sion, chest pain, or aneurysmal dilatation, the decision was
made to opt for medical management. BP was controlled
(<130 mmHg systolic) with intravenous b-blockade and
nitrate infusions, and subsequently with an oral regimen of
an aldosterone-antagonist, calcium-channel and b-
blockade (Fig. 2).
Seven months later the patient underwent elective lapa-
roscopic adrenalectomy; histology confirmed the diagnosis
of an adrenal adenoma. The patient’s BP has since been
tightly controlled on two anti-hypertensives at diminished
doses compared with pre-operative requirements. The
patient has entered a six-monthly imaging surveillance
program, which has shown the aortic diameter remains
stable and sub-threshold for intervention at 4.4 cm.
Discussion
The incidence of aortic dissection is approximately 3.0 per
100,000 per year.1 Refractory hypertension causes pres-
sure-induced damage to the intimal-medial layers of theFigure 1 MRI imaging showing aortic dissection and
a rounded mass arising from the left adrenal gland.arterial wall, rendering the vessel more vulnerable to
dissection. Hyperaldosteronism is rare cause of hyperten-
sion and usually asymptomatic but it should be considered,
particularly in young, hypokalaemic, or treatment resistant
patients. Excess aldosterone causes hypertension primarily
via sodium retention and increased circulating volume, and
increasing sympathetic activity. At high circulating levels, it
has been suggested that aldosterone acting at mineralo-
corticoid receptors mediates endocardial dysfunction,
myocardial fibrosis and cardiac remodelling.4 It may also
have a direct effect on matrix metalloproteinases and their
inhibitors leading to altered collagen content, altered
collagen/elastin ratios and medial necrosis, predisposing
the vessel to dissection.3
Accurate diagnosis, using biochemical analysis and cross-
sectional imaging (CT or MRI) is vital, as cases of unilateral
aldosterone hypersecretion are amenable to surgical
management whereas bilateral adrenocortical hyperplasia
is not.4,5 Surgery is the treatment of choice for proven
aldosterone-secreting adenomas.
Aortic dissection is most commonly seen in the 5the7th
decades followingmany years of degenerative, hypertensive
changes. This patient’s young age adds weight to the
e24 K.L. Harvey et al.hypothesis that another pathological process, beyond
hypertension alone, is contributing.
Conclusion
Primary hyperaldosteronism is a rare cause of hypertension
but should be considered in patients with resistant hyper-
tension or atypical groups, such as those aged <40 years or
advanced vascular disease. Although the triad of hyper-
tension, aldosterone-secreting adenoma and aortic dissec-
tion is a rare one, early recognition and definitive
management can eliminate the need for a complex vascular
intervention and improve outcomes.1,4 This is especially
important for young patients.
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